Get startedLog in
    Picture of ALX Oncology Holdings logo

    ALXO — ALX Oncology Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Alx Oncology Announces Initiation Of Phase 2 Investigator Sponsored Trial Of Neoadjuvant Radiation And Evorpacept

    Picture of ALX Oncology Holdings logoALX Oncology Holdings
    30/04/2024 14:15
    April 30 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY ANNOUNCES INITIATION OF PHASE 2
INVESTIGATOR-SPONSORED TRIAL OF NEOADJUVANT RADIATION AND
EVORPACEPT IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH
UNTREATED HPV-MEDIATED OROPHARYNGEAL CANCER

Source text for Eikon:  ID:nGNX4RMblg 
Further company coverage:  ALXO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on ALX Oncology Holdings

    See all news